• Publications
  • Influence
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.
Metastasis-related recurrence often occurs in hepatocellular carcinoma (HCC) patients who receive curative therapies. At present, it is challenging to identify patients with high risk of recurrence,Expand
  • 496
  • 50
  • PDF
Randomized controlled trial of screening for hepatocellular carcinoma
Purpose Screening for hepatocellular carcinoma (HCC) has been conducted for over 20 years, but there is no conclusive evidence that screening may reduce HCC mortality. The aim of this study was toExpand
  • 1,062
  • 44
Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
  • J. Zhou, L. Yu, +16 authors Jia Fan
  • Medicine
  • Journal of clinical oncology : official journal…
  • 20 December 2011
PURPOSE More than 60% of patients with hepatocellular carcinoma (HCC) do not receive curative therapy as a result of late clinical presentation and diagnosis. We aimed to identify plasma microRNAsExpand
  • 433
  • 26
  • PDF
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.
Hepatocellular carcinoma (HCC) is an aggressive malignancy mainly due to metastases or postsurgical recurrence. We postulate that metastases are influenced by the liver microenvironment. Here, weExpand
  • 641
  • 16
  • PDF
Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta‐catenin, T‐cell factor‐4 and glycogen synthase kinase 3‐beta genes
Background and Aims: Hepatocellular carcinoma (HCC) is a common killer cancer in the world. Recently, abnormal activation of the Wnt pathway has been found to be involved in the carcinogenesis ofExpand
  • 99
  • 8
Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.
OBJECTIVE To study severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. METHODS Clinical records of severe and rare complications following TACE in 1348 casesExpand
  • 143
  • 6
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival
BackgroundThe chemokine and bone marrow-homing receptor CXCR4 is implicated in metastases of various cancers. This study was conducted to analyze the association of CXCR4 expression withExpand
  • 83
  • 6
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Purpose: To investigate the role of macrophages in tumor progression under sorafenib treatment and to explore whether combination of drugs that deplete macrophages improved the antitumor effect ofExpand
  • 257
  • 5
  • PDF
Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
Purpose: Novel therapeutic strategies are needed to prevent the tumor recurrence or metastasis after liver transplantation for hepatocellular carcinoma (HCC). This study was to investigate the effectExpand
  • 133
  • 5
  • PDF
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.
The mechanism of cancer metastasis remains poorly understood. Using gene profiling of hepatocellular carcinoma (HCC) tissues, we have identified GOLM1 as a leading gene relating to HCC metastasis.Expand
  • 75
  • 5